Novartis AG is 73.2x more valuable than Oruka Therapeutics, Inc. by market capitalization ($282.64 B vs $3.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ORKA | NVS |
|---|---|---|
| Market cap | $3.86 B | $282.64 B |
| US-listed rank | #1601 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$105.43M | - |
| SEC filings | 1,475 | 947 |
Novartis AG is 73.2x more valuable than Oruka Therapeutics, Inc. by market capitalization ($282.64 B vs $3.86 B).
Full pages: Oruka Therapeutics, Inc. and Novartis AG, or browse the full rankings.